The Journal of Organic Chemistry
Note
calcd for C25H20N5O+: 445.2135), 344.9848 (74), 304.2616 (99),
262.9819 (83).
C(3″,5″)), 7.14 (d, J = 9.1 Hz, 2 H; H−C(2″,6″)), 7.23 (d, J = 9.2 Hz,
2 H; H−C(2′,6′)), 7.87 ppm (s, 1 H; H−C(4)); 13C NMR (100 MHz,
CD2Cl2) δ = 25.3 (C(3,4) of pyrrolidin-1-yl), 40.0 (NMe2), 48.1
(C(2,5) of pyrrolidin-1-yl), 74.0 and 77.4 (C(1,6)), 111.4 and 112.2
(C(3′,5′,3″,5″)), 113.5 (CN), 113.6 (CN), 114.2 (CN), 114.7 (CN),
115.1 (CN), 119.3 and 119.5 (C(1′,1″)), 122.8 (C(3)), 131.8 and
132.3 (C(2′,6′,2″,6″)), 150.3 (C(4)), 152.2 (C(4′)), 154.1 (C(4″)),
(E)-2,5-Bis[4-(dibutylamino)phenyl]hexa-1,3,5-triene-
1,1,6,6-tetracarbonitrile (3d). A solution of 2d (466 mg, 0.2 mmol)
and TCNE (130 mg, 0.1 mmol) in CHCl3 (30 mL) was stirred at 50
°C for 36 h and evaporated. FC (SiO2; CH2Cl2) gave 3d (506 mg,
85%) as a purple solid. Rf = 0.49 (SiO2; CH2Cl2); mp 206−207 °C; 1H
NMR (400 MHz, CD2Cl2) δ = 0.98 (t, J = 7.3 Hz, 12 H; 4 Me), 1.35
− 1.42 (m, 8 H; 4 CH2Me), 1.60−1.67 (m, 8 H; 2 N(CH2CH2)2),
3.39 (br. t, J = 7.8 Hz, 8 H; 2 N(CH2)2), 6.75 (d, J = 9.2 Hz, 4 H; H−
C(3′,5′)), 7.27 (s, 2 H; H−C(3)), 7.49 ppm (d, J = 9.1 Hz, 4 H; H−
C(2′,6′)); 13C NMR (100 MHz, CD2Cl2) δ = 14.2 (2 Me), 20.8 (2
CH2Me), 29.8 (N(CH2CH2)2), 51.4 (N(CH2)2), 78.9 (C(1)), 111.8
(C(3′,5′)), 114.6 (CN), 115.6 (CN), 118.5 (C(1′)), 133.1 (C(2′,6′)),
̃
159.8 (C(5)), 162.6 ppm (C(2)); IR (ATR) ν = 3018 (w), 2981 (w),
2924 (w), 2860 (w), 2214 (m), 1602 (s), 1537 (w), 1491 (s), 1443
(m), 1407 (s), 1375 (m), 1345 (m), 1284 (w), 1209 (m), 1186 (m),
818 (m), 752 (m), 667 cm−1 (w); HR-ESI-MS m/z (%) 492.1906 (34,
[M + Na]+, calcd for C29H23N7Na+: 492.1907), 470.2090 (11, [M +
+
H]+, calcd for C29H24N7 : 470.2088), 420.9703 (33), 344.9844 (54),
262.9813 (61), 256.9645 (100).
(3E,5E)- and (3Z,5E)-2,4,7-Tris[4-(dimethylamino)phenyl]-
octa-1,3,5,7-tetraene-1,1,3,8,8-pentacarbonitrile ((3E,5E)/
(3Z,5E)-5). A solution of 3-[4-(dimethylamino)phenyl]propiolonitrile
(129 mg, 0.76 mmol) and TCNE (97 mg, 0.76 mmol) in toluene (30
mL) was stirred at 90 °C for 24 h, treated with 2a (220 mg, 1.52
mmol), and stirred at 90 °C for 48 h. Evaporation and FC (SiO2;
CH2Cl2) gave a 7:3 mixture of (3E,5E)/(3Z,5E)-5 (335 mg, 75%) as a
brownish-black solid. Rf = 0.64 (SiO2; CH2Cl2/EtOAc 98:2); 1H NMR
(400 MHz, CD2Cl2; (3E,5E)/(3Z,5E) 7:3) δ = 3.02 and 3.06 (2s, 1.8
and 4.2 H; NMe2), 3.10 (s, 6 H; NMe2), 3.11 (s, 6 H; NMe2), 6.64 (d,
J = 9.0 Hz, 0.6 H) and 6.77 (d, J = 9.1 Hz, 1.4 H), 6.71 (d, J = 9.3 Hz,
2 H), 6.86 (d, J = 9.0 Hz, 2 H) (3x H−C(3′,5′)), 6.80 (d, J = 15.2 Hz,
0.7 H), 7.19 (d, J = 15.2 Hz, 0.7 H), 7.24 (d, J = 15.2 Hz, 0.3 H), 7.50
(d, J = 15.1 Hz, 0.3 H) (H−C(5,6)), 7.13 (d, J = 9.0 Hz, 0.6 H), 7.36
(d, J = 9.1 Hz, 1.4 H), 7.50 (d, J = 9.0 Hz, 1.4 H), 7.52 (d, J ≈ 8.3 Hz,
0.6 H), 7.65 (d, J = 9.2 Hz, 1.4 H) 7.70 ppm (d, J = 9.2 Hz, 0.6 H) (3×
H−C(2′,6′); 13C NMR (100 MHz, CD2Cl2; (3E,5E)/(3Z,5E) 7:3)
signals of (3E,5E): δ = 40.4, 40.5, 40.5, 76.8, 79.7, 80.3, 109.2, 114.4,
115.3, 115.4, 115.7, 118.0, 119.0, 119.2, 121.7, 132.4, 132.5, 133.4,
139.8, 142.4, 153.3, 153.9, 155.0, 161.7, 163.1, 168.7, signals of (3Z,5E,
two signals are overlapping) δ = 40.44, 40.49, 78.1, 80.3, 108.6, 112.0,
114.3, 115.1, 115.4, 116.7, 119.4, 119.7, 120.4, 131.9, 132.6, 133.1,
̃
142.1 (C(3)), 152.6 (C(4′)), 167.2 ppm (C(2)); IR (ATR) ν = 2954
(m), 2928 (m), 2862 (w), 2213 (m), 1594 (s), 1533 (w), 1482 (s),
1435 (w), 1411 (m), 1366 (m), 1341 (s), 1289 (w), 1275 (m), 1230
(w), 1205 (m), 1187 (s), 1162 (m), 1105 (m), 991 (w), 976 (w), 925
(w), 820 (s), 798 (w), 763 (w), 738 (w), 692 cm−1 (w); HR-ESI-MS
+
m/z (%) 587.3846 (100, [M + H]+, calcd for C38H47N6 : 587.3857),
338.3414 (75).
(E)-2,5-Bis(4-methoxyphenyl)hexa-1,3,5-triene-1,1,6,6-tetra-
carbonitrile (3e). A solution of 2e (307 mg, 2.33 mmol) and TCNE
(149 mg, 1.16 mmol) in (CHCl2)2 (10 mL) was stirred at 120 °C for
60 h and evaporated. FC (SiO2; CH2Cl2) gave 3e (137 mg, 30%) as a
red solid and 1b6b (182 mg, 60%). Rf = 0.30 (SiO2; CH2Cl2); mp
271−272 °C; 1H NMR (400 MHz, CD2Cl2) δ = 3.91 (s, 6 H; OMe),
7.11 (d, J = 8.9 Hz, 4 H; H−C(2′,6′)), 7.26 (s, 2 H; H−C(3)), 7.44
ppm (d, J = 8.9 Hz, 4 H; H−C(3′,5′)); 13C NMR (100 MHz, CD2Cl2)
δ = 55.7 (OMe), 87.0 (C(1)), 112.0 (CN), 113.0 (CN), 114.8
(C(3′,5′)), 123.5 (C(1′)), 131.3 (C(2′,6′)), 141.2 (C(3)), 163.2
̃
(C(4′)), 167.3 ppm (C(2)); IR (ATR) ν = 3110 (w), 3075 (w), 3038
(w), 2958 (w), 2937 (w), 2913 (w), 2840 (w), 2225 (s), 1601 (s),
1575 (m), 1531 (m), 1507 (s), 1446 (w), 1442 (w), 1426 (w), 1335
(m), 1309 (m), 1285 (s), 1264 (s), 1182 (s), 1127 (w), 1108 (m),
1026 (s), 1011 (m), 992 (m), 972 (w), 959 (w), 843 (s), 830 (m), 793
(w), 741 (m), 697 (w), 632 cm−1 (w); HR-ESI-MS m/z (%) 415.1155
139.7, 144.7, 152.8, 154.0, 154.6, 161.4, 164.5, 168.7 ppm; IR (ATR) ν
̃
= 2911 (w), 2864 (w), 2811 (w), 2214 (m), 1601 (s), 1542 (w), 1489
(m), 1438 (w), 1377 (m), 1340 (m), 1209 (m), 1190 (m), 1167 (m),
944 (w), 820 cm−1 (w); HR-ESI/MALDI-MS (dual, DCTB as matrix)
+
(100, [M + Na]+, calcd for C24H16N4NaO2 : 415.1165), 344.9838
(52), 304.2606 (63), 268.9981 (53), 262.9811 (57), 186.9787 (41).
(Z)-5-[4-(Dimethylamino)phenyl]-2-[4-(pyrrolidin-1-yl)-
phenyl]hexa-1,3,5-triene-1,1,3,6,6-pentacarbonitrile (Z-4a)
and (E)-5-[4-(Dimethylamino)phenyl]-2-[4-(pyrrolidin-1-yl)-
phenyl]hexa-1,3,5-triene-1,1,3,6,6-pentacarbonitrile (E-4b). In
a sealed tube, a solution of 2c (213 mg, 1.1 mmol) and 1a (270 mg, 1
mmol) in (CHCl2)2 (10 mL) was stirred at 120 °C for 24 h.
Evaporation and FC (SiO2; CH2Cl2 → CH2Cl2/EtOAc 98:2) gave Z-
4a (172 mg, 37%) as a bluish-maroon solid and E-4b (23 mg, 5%) as a
brownish-black solid.
+
m/z (%) 588.2750 (100, [M]+, calcd for C37H32N8 : 588.2746).
ASSOCIATED CONTENT
* Supporting Information
■
S
1H and 13C NMR spectra, quinoidal character, and electro-
chemistry of all new compounds; and crystal structure data for
compounds 3a, 3c, 3d, 3e, Z-4a, E-4b, and (3E,5E)-5. This
material is available free of charge via the Internet at http://
Z-4a: Rf = 0.48 (SiO2; CH2Cl2/EtOAc 98:2); mp 227.5−228.5 °C;
1H NMR (400 MHz, CD2Cl2) δ = 2.06 (m, 4 H; H2C(3,4) of
pyrrolidin-1-yl), 3.14 (s, 6 H; NMe2), 3.46 (m, 4 H; H2C(2,5) of
pyrrolidin-1-yl), 6.67 (d, J = 9.2 Hz, 2 H; H−C(3′,5′)), 6.80 (d, J = 9.3
Hz, 2 H; H−C(3″,5″)), 7.69 (s, 1 H; H−C(4)), 7.75 (d, J = 9.2 Hz, 2
H; H−C(2′,6′)), 7.80 ppm (d, J = 9.3 Hz, 2 H; H−C(2″,6″)); 13C
NMR (100 MHz, CD2Cl2) δ = 25.8 (C(3,4) of pyrrolidin-1-yl), 40.5
(NMe2), 48.6 (C(2,5) of pyrrolidin-1-yl), 74.5 and 77.1 (C(1,6)),
112.3 and 112.9 (C(3′,5′,3″,5″)), 113.3 (NC−C(3)), 114.9 (CN),
115.0 (CN), 115.4 (CN), 115.5 (CN), 118.0 and 119.1 (C(1′,1″)),
122.0 (C(3)), 133.1 and 133.6 (C(2′,6′,2″,6″)), 150.1 (C(4)), 152.9
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
̃
(C(4′)), 154.9 (C(4″)), 162.3 and 162.4 ppm (C(2,5)); IR (ATR) ν =
This work was supported by the ERC Advanced grant no.
246637 (“OPTELOMAC”). A.D.F. acknowledges the NSF-
IRFP (USA) for a postdoctoral fellowship.
3018 (w), 2981 (w), 2953 (w), 2924 (w), 2865 (w), 2214 (m), 1603
(s), 1495 (m), 1443 (m), 1409 (m), 1383 (m), 1340 (m), 1209 (m),
1186 (m), 820 (w), 750 cm−1 (w); HR-ESI-MS m/z (%) 492.1902
(100, [M + Na]+, calcd for C29H23N7Na+: 492.1907), 470.2086 (40,
+
[M + H]+, calcd for C29H24N7 : 470.2088), 344.9843 (93), 262.9815
REFERENCES
■
(100), 173.0783 (95), 158.9966 (78).
(1) Etemad, S.; Heeger, A. J.; MacDiarmid, A. G. Annu. Rev. Phys.
Chem. 1982, 33, 443−469.
(2) (a) Omura, S.; Tanaka, H. In Macrolide Antibiotics: Chemistry,
Biology, and Practice; Omura, S., Ed.; Academic Press: New York, 1984;
pp 351−404. (b) Rychnovsky, S. D. Chem. Rev. 1995, 95, 2021−2040.
E-4b: Rf = 0.38 (SiO2; CH2Cl2/EtOAc 98:2); mp 180−181 °C; 1H
NMR (400 MHz, CD2Cl2) δ = 2.09 (m, 4 H; H2C(3,4) of pyrrolidin-
1-yl), 3.13 (s, 6 H; NMe2), 3.46 (m, 4 H; H2C(2,5) of pyrrolidin-1-yl),
6.51 (d, J = 9.2 Hz, 2 H; H−C(3′,5′)), 6.62 (d, J = 9.1 Hz, 2 H; H−
430
dx.doi.org/10.1021/jo402440m | J. Org. Chem. 2014, 79, 426−431